PND33 A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.817
https://www.valueinhealthjournal.com/article/S1098-3015(21)01034-2/fulltext
Section Title :
Section Order :
10317
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01034-2&doi=10.1016/j.jval.2021.04.817